Back to search
FDAFDA · Food and drugs·Recall number D-1687-2012

10% Dextrose Injection USP, packaged in a 500 mL AVIVA Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; product code 6E0163, NDC 0338-6347-03

Published October 3, 2012 · Recall initiated: September 21, 2012

Summary

FDA records drug Class II recall D-1687-2012, published October 3, 2012 and initiated September 21, 2012. Recalling firm: Baxter Healthcare Corp.; Status: Terminated; Reported quantity: 2,976 containers; Lot: Lot #: C832840, Exp 02/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corp.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: C832840, Exp 02/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 10% Dextrose Injection USP, packaged in a 500 mL AVIVA Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; product code 6E0163, NDC 0338-6347-03 recalled?

Yes. FDA published recall D-1687-2012 on October 3, 2012. Reported hazard: Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).

What should I do if I have this product?

Voluntary: Firm initiated · Letter